Mark R Kelley

ISNI Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Topics

Vascular Endothelial Growth Factor

Cell Proliferation

Dna Damage Response

Top Venues

International journal of molecular sciences

The Journal of pharmacology and experimental therapeutics

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren Sahakian, Ainsley M Robinson, Linda Sahakian, Rhian Stavely, Mark R Kelley, Kulmira Nurgali
APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease. Biomolecules 13 (11) (2023)
Mahmut Mijit, Sheng Liu, Kamakshi L Sishtla, Gabriella D Hartman, Jun Wan, Timothy W Corson, Mark R Kelley
Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. International journal of molecular sciences 24 (2) (2023)
Mahmut Mijit, Sheng Liu, Kamakshi L Sishtla, Gabriella D Hartman, Jun Wan, Timothy W Corson, Mark R Kelley
Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. International journal of molecular sciences 24 (2) (2023)
Anbukkarasi Muniyandi, Gabriella D Hartman, Yang Song, Mahmut Mijit, Mark R Kelley, Timothy W Corson
Beyond VEGF: targeting inflammation and other pathways for treatment of retinal disease . The Journal of pharmacology and experimental therapeutics (2023)
Mahmut Mijit, Sheng Liu, Kamakshi L Sishtla, Gabriella D Hartman, Jun Wan, Timothy W Corson, Mark R Kelley
Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. International journal of molecular sciences 24 (2) (2023)
Larissa L Silva, Robert E Stratford, Richard Messmann, Mark R Kelley, Sara K Quinney
Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330. CPT: pharmacometrics & systems pharmacology (2023)
Mahmut Mijit, Sheng Liu, Kamakshi L Sishtla, Gabriella D Hartman, Jun Wan, Timothy W Corson, Mark R Kelley
Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. International journal of molecular sciences 24 (2) (2023)
Anbukkarasi Muniyandi, Gabriella D Hartman, Yang Song, Mahmut Mijit, Mark R Kelley, Timothy W Corson
Beyond VEGF: targeting inflammation and other pathways for treatment of retinal disease . The Journal of pharmacology and experimental therapeutics (2023)
Mahmut Mijit, Sheng Liu, Kamakshi L Sishtla, Gabriella D Hartman, Jun Wan, Timothy W Corson, Mark R Kelley
Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. International journal of molecular sciences 24 (2) (2023)
Jesse D Champion, Kayleigh M Dodd, Hilaire C Lam, Mohammad A M Alzahrani, Sara Seifan, Ellie Rad, David Oliver Scourfield, Melissa L Fishel, Brian L Calver, Ann Ager, Elizabeth P Henske, David Mark Davies, Mark R Kelley, Andrew R Tee
Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells. Cancers 14 (24) (2022)
Jesse D Champion, Kayleigh M Dodd, Hilaire C Lam, Mohammad A M Alzahrani, Sara Seifan, Ellie Rad, David Oliver Scourfield, Melissa L Fishel, Brian L Calver, Ann Ager, Elizabeth P Henske, David Mark Davies, Mark R Kelley, Andrew R Tee
Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells. Cancers 14 (24) (2022)
Jesse D Champion, Kayleigh M Dodd, Hilaire C Lam, Mohammad A M Alzahrani, Sara Seifan, Ellie Rad, David Oliver Scourfield, Melissa L Fishel, Brian L Calver, Ann Ager, Elizabeth P Henske, David Mark Davies, Mark R Kelley, Andrew R Tee
Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells. Cancers 14 (24) (2022)
Jesse D Champion, Kayleigh M Dodd, Hilaire C Lam, Mohammad A M Alzahrani, Sara Seifan, Ellie Rad, David Oliver Scourfield, Melissa L Fishel, Brian L Calver, Ann Ager, Elizabeth P Henske, David Mark Davies, Mark R Kelley, Andrew R Tee
Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells. Cancers 14 (24) (2022)
Adib Behrouzi, Hanyu Xia, Eric L Thompson, Mark R Kelley, Jill C Fehrenbacher
Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons. International journal of molecular sciences 23 (3) (2022)
Melissa L Fishel, Hanyu Xia, Jack McGeown, David W McIlwain, May Elbanna, Ariel A Craft, Hristos Z Kaimakliotis, George E Sandusky, Chi Zhang, Roberto Pili, Mark R Kelley, Travis J Jerde
Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer. Molecular cancer therapeutics 18 (11) (2019)
Sheik Pran Babu Sardar Pasha, Kamakshi L Sishtla, Rania S Sulaiman, Bomina Park, Trupti Shetty, Fenil Shah, Melissa L Fishel, James H Wikel, Mark R Kelley, Timothy W Corson
Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization. The Journal of pharmacology and experimental therapeutics 367 (1) (2018)